Clinical Practice Guideline

Guidelines in Development

September 17, 2021

Listed below are the current guidelines and updates in development. Topics are prioritized for development by the Clinical Guidelines Committee. During the development process, guidelines are made available for open comment to identify any errors or gaps in the draft guideline prior to publication to ensure greater transparency. Check back here for opportunities to submit topics for consideration and to review guidelines open for comment when available. To learn more about the Endocrine Society guideline development process, access the guideline development methodology page.  


The Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings
Anticipated Publication: Summer 2022
This is an update to the 2012 guideline.  It will provide recommendations for the non-critically ill hospitalized patient population with diabetes or with newly recognized or stress induced hyperglycemia.  


Evaluation and Management of Hypoglycemic Disorders
Anticipated Publication: Summer 2022
This is an update to the 2009 guideline.  It will provide recommendations for patients with diabetes related hypoglycemia in the inpatient and outpatient setting.


Malignant Hypercalcemia
Anticipated Publication: Summer 2022
This new guideline will provide recommendations for patients with hypercalcemia of malignancy or hypercalcemia due to parathyroid carcinoma.


Vitamin D
Anticipated Publication: Summer 2023
This is an update to the 2011 guideline.


Diabetes in Pregnancy
Anticipated Publication: Spring 2024
This guideline is a collaboration with the European Society of Endocrinology.


The Management of Primary Aldosteronism
Anticipated Publication: Spring 2024
This is an update to the 2016 guideline.


Retired Guidelines

Endocrine Society guidelines can be retired for any of the following reasons: the guideline as a whole is sufficiently out of date that it is no longer relevant to clinical practice; one or more of the guideline recommendations contain important inaccuracies or omissions that, if followed precisely, could lead to substandard patient care or potential harm; or the guideline has been replaced by a more recent publication.

Last Updated:
Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!